Hemerus Medical, LLC
Hemerus Medical, LLC specializes in designing and developing innovative blood collection, processing, preservation, and storage technologies. Our mission is to improve patient transfusion outcomes and ensure the availability of high-quality, life-saving blood products. Hemerus aims to extend the shelf life of blood products and enhance transfusion safety through advanced technologies like leukocyte reduction filters and novel anticoagulant and additive solutions.
Hemerus Medical, LLC
5000 Township Parkway, Saint Paul, MN 55110-5852, USA
Hemerus Medical, LLC is currently seeking investment
Hemerus Medical, LLC is seeking a series-a investment in the range of 5m-20m
Patents
Blood storage container containing aqueous composition for the storage of red blood cells
2024-12-31 • US-12178779-B2
View DetailsBlood storage container containing aqueous composition for the storage of red blood cells
2023-08-22 • US-11730676-B2
View DetailsWhat We Do
The SOLX™ System is FDA approved for pre-storage leukocyte reduction of CPD whole blood and preparation of AS-7 Red Cells, Leukocytes Reduced. It also includes preparation of Fresh Frozen Plasma and Plasma Frozen Within 24 Hours After Phlebotomy. The system is expected to be available for sale in October 2025.
LEUP™ processing circuit technology enables leukoreduction of blood products in a one-step, vent-free process, improving efficiency and freeing up operators' time.
LEUKOSEP™ filters are designed to effectively remove leukocytes from blood products, providing high efficiency leukoreduction with low residual hold up.
Biologics
Key People
News & Updates
Hemerus Medical received patents for developing DEHP-free blood collection and storage systems, addressing health and environmental concerns.
Hemerus Medical Receives CE Marking for World's First 56 Day Red Blood Cell Storage Solution - SOLX®
SOLX® was the result of a collaborative effort between the US Army, the University of Cincinnati and Hemerus. The SOLX® storage solution research was initially funded by the US Army, and invented by Dr. John Hess of the University of Maryland, and the late Dr. Tibor Greenwalt of the University of Cincinnati. Hemerus furthered this research through its development of a whole blood leukoreduction collection set and performed clinical trials, which were also partially funded by the US Army. Hemerus holds the exclusive worldwide license to the intellectual property.
The SOLX® system is a whole blood collection system that produces Leukoreduced red blood cells and plasma. This system has been approved in the United States by the FDA for six weeks red blood cell storage and was previously approved in Europe for eight weeks red blood cell storage.
Hemerus Medical, LLC, a leader in innovative blood collection, storage, and preservation technologies, announces its commitment to eliminating Substances of Very High Concern (SVHC), such as phthalate plasticizers like di(2-ethylhexyl) phthalate (DEHP) from blood collection and storage sets.